- Release Date: 27/10/14 08:30
- Summary: CSL to acquire Novartis influenza vaccine business
- Price Sensitive: Yes
- Download Document 442.42KB
- Forums
- ASX - By Stock
- CSL
- Ann: CSL to acquire Novartis influenza vaccine business
CSL
csl limited
Add to My Watchlist
2.05%
!
$269.74

Ann: CSL to acquire Novartis influenza vaccine business
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$269.74 |
Change
5.430(2.05%) |
Mkt cap ! $130.4B |
Open | High | Low | Value | Volume |
$265.01 | $270.48 | $264.38 | $114.8M | 427.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13 | $269.73 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$269.75 | 405 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 5 | 269.690 |
4 | 35 | 269.680 |
3 | 11 | 269.670 |
2 | 24 | 269.660 |
3 | 30 | 269.640 |
Price($) | Vol. | No. |
---|---|---|
269.710 | 44 | 11 |
269.720 | 10 | 1 |
269.730 | 45 | 3 |
269.750 | 10 | 2 |
269.760 | 38 | 5 |
Last trade - 14.36pm 13/08/2025 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |